Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2015 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (266)	3/27/2015 7:46:54 PM
From: A.J. Mullen	Respond to of 407

I said I was going for a volatile portfolio. Only two stocks have given me that volatility: Genfit and Senomyx. Unfortunately both have declined rather than risen. They were originally 40% of my portfolio, so I'm among the select few who are underwater for the year. Ashley

To: BulbaMan who wrote (266)	4/3/2015 4:23:30 PM
From: BulbaMan	2 Recommendations Recommended By IRWIN JAMES FRANKEL rkrw Read Replies (1) \| Respond to of 407

4/3/15 Contest update Travel Alert: Taking a tip from Satchmo (see link below), my wife & I will be spending the rest of April in Portugal. She’ll be busy sketching & I’ll be busy noshing on bacalao & pasteis de nata. So no Contest updates until May. youtube.com TGIGF! Yeah, thank goodness it’s Good Friday. So panicky investors were unable to dump their stocks in reaction to today’s lousy job report. Let’s hope the cloud of fear will pass over by Monday. Meanwhile, a big move by the most popular Contest portfolio pick, TRIL, gave the median a hefty boost. And at the end of the shortened trading week, the Contest median closed up 21.78% YTD (vs. up 17.69% YTD last Friday). However, the Nasdaq Biotech Index did not fare as well, closing up 11.85% YTD (vs. up 14.43% YTD last Friday), while the smaller-cap S&P Biotechnology Select Industry Index was up 18.09% YTD (vs. up 17.66% YTD last Friday). The Nasdaq Composite Index closed up 3.19% YTD (vs. up 3.28% YTD last Friday). OHM’s portfolio, up 54.06% YTD, hopped into the Contest lead, while IMAN’s portfolio, up 53.08% YTD, slid to second place. But the major surprise of the week was BIOMAV’s portfolio, now up 52.08% YTD. Propelled by 20% allocations to TRIL & RTRX, it leapfrogged out of the pack into third place. At Friday's close, 47 of the 51 Contest portfolios were still in the black with an astonishing 37 beating the NBI and 29 beating the SPSIBI. The 206 Contest stock picks have an average YTD gain of 16.55%. Below is the Top Ten list. Also below are the week’s Top 5 & Bottom 5 Stocks. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None (All corrections, especially adjustments for buyouts & splits, greatly appreciated.) Happy Spring Holidays to all the biotechies out there! Peace & good health, Bulba 4/2/15 Rank Name Profit/Loss 1 OHMS 54,059 2 IMAN 53,083 3 BIOMAV 52,079 4 MCBIO 49,733 5 DEWDIL 48,991 6 GADGET 48,338 7 CLARK 47,427 8 DANIEL 46,811 9 DONS 44,301 10 THEOX 40,156 Week's Top 5 Gainers Symbol 3/27/15 4/2/15 Wk.%chg. EKSO 1.390 2.090 50.36% EDT.TO 0.750 1.080 44.00% ASPX 70.910 100.550 41.80% TRIL 18.370 25.020 36.20% GBIM 7.400 9.690 30.95% Week's Worst 5 Losers Symbol 3/27/15 4/2/15 Wk.%chg. BDSI 13.890 10.030 -27.79% CNAT 7.750 6.130 -20.90% AKAO 9.700 7.860 -18.97% CLDN 21.090 17.730 -15.93% AMF.TO 0.035 0.030 -14.29%